83 related articles for article (PubMed ID: 12491799)
1. Structure-activity relationship studies of phenoxypropanolamine derivatives for beta 3-adrenergic activity.
Ahmed M; Hanaoka Y; Nagatomo T
Nihon Yakurigaku Zasshi; 2002 Nov; 120(1):112P-113P. PubMed ID: 12491799
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the binding affinity of some newly synthesized phenylethanolamine and phenoxypropanolamine compounds at recombinant human beta- and alpha1-adrenoceptor subtypes.
Ahmed M; Hanaoka Y; Kiso T; Kakita T; Ohtsubo Y; Muramatsu I; Nagatomo T
J Pharm Pharmacol; 2005 Jan; 57(1):75-81. PubMed ID: 15638996
[TBL] [Abstract][Full Text] [Related]
3. Molecular modeling of SWR-0342SA, a beta3-selective agonist, with beta1- and beta3-adrenoceptor.
Ahmed M; Ishiguro M; Nagatomo T
Life Sci; 2006 Mar; 78(17):2019-23. PubMed ID: 16310810
[TBL] [Abstract][Full Text] [Related]
4. Binding and functional affinity of some newly synthesized phenethylamine and phenoxypropanolamine derivatives for their agonistic activity at recombinant human beta3-adrenoceptor.
Ahmed M; Hanaoka Y; Nagatomo T; Kiso T; Kakita T; Kurose H; Nagao T
J Pharm Pharmacol; 2003 Jan; 55(1):95-101. PubMed ID: 12625872
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of pharmacological properties and selectivity of SWR-0315NA for beta3-adrenoceptors.
Ahmed M; Hanaoka Y; Kiso T; Kakita T; Ohtsubo Y; Nagatomo T
Biol Pharm Bull; 2004 May; 27(5):718-22. PubMed ID: 15133253
[TBL] [Abstract][Full Text] [Related]
6. Anti-obesity and anti-diabetic activities of a new beta3 adrenergic receptor agonist, (S)-(Z)-[4-[[1-[2-[(2-hydroxy-3-phenoxypropyl)]amino]ethyl]-1-propenyl] phenoxy] acetic acid ethanedioic acid (SWR-0342SA), in KK-Ay mice.
Kiso T; Namikawa T; Tokunaga T; Sawada K; Kakita T; Shogaki T; Ohtsubo Y
Biol Pharm Bull; 1999 Oct; 22(10):1073-8. PubMed ID: 10549858
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of novel phenoxypropanolamine derivatives containing acetanilides as potent and selective beta3-adrenergic receptor agonists.
Maruyama T; Onda K; Hayakawa M; Seki N; Takahashi T; Moritomo H; Suzuki T; Matsui T; Takasu T; Nagase I; Ohta M
Bioorg Med Chem; 2009 May; 17(9):3283-94. PubMed ID: 19362005
[TBL] [Abstract][Full Text] [Related]
8. Potent and selective human beta(3)-adrenergic receptor antagonists.
Candelore MR; Deng L; Tota L; Guan XM; Amend A; Liu Y; Newbold R; Cascieri MA; Weber AE
J Pharmacol Exp Ther; 1999 Aug; 290(2):649-55. PubMed ID: 10411574
[TBL] [Abstract][Full Text] [Related]
9. Isomeric-activity ratios of trimetoquinol enantiomers on beta-adrenergic receptor subtypes: functional and biochemical studies.
Fraundorfer PF; Lezama EJ; Salazar-Bookaman MM; Fertel RH; Miller DD; Feller DR
Chirality; 1994; 6(2):76-85. PubMed ID: 7911313
[TBL] [Abstract][Full Text] [Related]
10. The tertiary amine nitrogen atom of piperazine sulfonamides as a novel determinant of potent and selective beta3-adrenoceptor agonists.
Perrone MG; Bleve L; Santandrea E; Vitale P; Niso M; Scilimati A
ChemMedChem; 2009 Dec; 4(12):2080-97. PubMed ID: 19882697
[TBL] [Abstract][Full Text] [Related]
11. Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta 3-adrenoceptor and rodent intestinal beta 3-adrenoceptors.
Molenaar P; Sarsero D; Arch JR; Kelly J; Henson SM; Kaumann AJ
Br J Pharmacol; 1997 Jan; 120(2):165-76. PubMed ID: 9117106
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel thiourea derivatives as potent and selective beta3-adrenergic receptor agonists.
Maruyama T; Seki N; Onda K; Suzuki T; Kawazoe S; Hayakawa M; Matsui T; Takasu T; Ohta M
Bioorg Med Chem; 2009 Aug; 17(15):5510-9. PubMed ID: 19581100
[TBL] [Abstract][Full Text] [Related]
13. Novel chiral isoxazole derivatives: synthesis and pharmacological characterization at human beta-adrenergic receptor subtypes.
Dallanoce C; Frigerio F; De Amici M; Dorsch S; Klotz KN; De Micheli C
Bioorg Med Chem; 2007 Apr; 15(7):2533-43. PubMed ID: 17303428
[TBL] [Abstract][Full Text] [Related]
14. CoMFA analysis of the human beta(1)-adrenoceptor binding affinity of a series of phenoxypropanolamines.
Louis SN; Rezmann-Vitti LA; Nero TL; Iakovidis D; Jackman GP; Louis WJ
Eur J Med Chem; 2002 Feb; 37(2):111-25. PubMed ID: 11858844
[TBL] [Abstract][Full Text] [Related]
15. Quantitative structure-activity relationship study of iodinated analogues of trimetoquinol as highly potent beta 2-adrenoceptor ligands.
Kumar R; Singh P
Indian J Biochem Biophys; 1998 Dec; 35(6):390-2. PubMed ID: 10412236
[TBL] [Abstract][Full Text] [Related]
16. Structural and conformational features determining selective signal transduction in the beta 3-adrenergic receptor.
Blin N; Camoin L; Maigret B; Strosberg AD
Mol Pharmacol; 1993 Dec; 44(6):1094-104. PubMed ID: 7903415
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and pharmacological characterization of high-affinity trimetoquinol analogs on guinea pig and human beta adrenergic receptor subtypes: evidence for partial agonism.
Fraundorfer PF; Fertel RH; Miller DD; Feller DR
J Pharmacol Exp Ther; 1994 Aug; 270(2):665-74. PubMed ID: 7915318
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of N-phenyl-(2-aminothiazol-4-yl)acetamides with phenoxypropanolamine moiety as selective β3-adrenergic receptor agonists.
Maruyama T; Onda K; Suzuki T; Hayakawa M; Takahashi T; Matsui T; Takasu T; Nagase I; Ohta M
Chem Pharm Bull (Tokyo); 2012; 60(5):647-58. PubMed ID: 22689403
[TBL] [Abstract][Full Text] [Related]
19. Iodinated analogs of trimetoquinol as highly potent and selective beta 2-adrenoceptor ligands.
De Los Angeles JE; Nikulin VI; Shams G; Konkar AA; Mehta R; Feller DR; Miller DD
J Med Chem; 1996 Sep; 39(19):3701-11. PubMed ID: 8809159
[TBL] [Abstract][Full Text] [Related]
20. 2-Amino-4-benzyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridines: novel selective beta3-adrenoceptor agonists.
Zheng W; Nikulin VI; Konkar AA; Vansal SS; Shams G; Feller DR; Miller DD
J Med Chem; 1999 Jun; 42(12):2287-94. PubMed ID: 10377236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
